Search results
Showing 31 to 45 of 352 results for covid
Awaiting development [GID-TA11224] Expected publication date: TBC
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)
This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS (COPD–OSAHS overlap syndrome) in people over 16. It aims to improve recognition, investigation and treatment of these related conditions.
This guideline covers assessment of people aged 16 and over with symptoms and signs of acute respiratory infection (bacterial or viral) at first remote or in-person contact with NHS services. It also covers the initial management of any infections. It aims to support healthcare practitioners in making sure that people’s treatment follows the best care pathway. It forms part of a suite of work on virtual wards being undertaken by NICE.
This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.
Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19...
risk of new COVID-19 and severity of COVID-19: Does radiation-induced lymphopenia predispose...
Awaiting development [GID-TA11227] Expected publication date: TBC
Awaiting development [GID-TA11226] Expected publication date: TBC
Vitamin D: supplement use in specific population groups (PH56)
This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and people with dark skin.
systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and...
efficacy and safety of COVID-specific antiviral drugs in combination with other COVID-specific...
Awaiting development [GID-QS10094] Expected publication date: TBC
In development [GID-QS10113] Expected publication date: TBC
This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.
Find out about the progress made by the health and care system in implementing NICE guidance on prostate cancer